An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes

JCI Insight. 2017 Sep 7;2(17):e94387. doi: 10.1172/jci.insight.94387.

Abstract

Human endogenous retroviruses (HERVs), remnants of ancestral viral genomic insertions, are known to represent 8% of the human genome and are associated with several pathologies. In particular, the envelope protein of HERV-W family (HERV-W-Env) has been involved in multiple sclerosis pathogenesis. Investigations to detect HERV-W-Env in a few other autoimmune diseases were negative, except in type-1 diabetes (T1D). In patients suffering from T1D, HERV-W-Env protein was detected in 70% of sera, and its corresponding RNA was detected in 57% of peripheral blood mononuclear cells. While studies on human Langerhans islets evidenced the inhibition of insulin secretion by HERV-W-Env, this endogenous protein was found to be expressed by acinar cells in 75% of human T1D pancreata. An extensive immunohistological analysis further revealed a significant correlation between HERV-W-Env expression and macrophage infiltrates in the exocrine part of human pancreata. Such findings were corroborated by in vivo studies on transgenic mice expressing HERV-W-env gene, which displayed hyperglycemia and decreased levels of insulin, along with immune cell infiltrates in their pancreas. Altogether, these results strongly suggest an involvement of HERV-W-Env in T1D pathogenesis. They also provide potentially novel therapeutic perspectives, since unveiling a pathogenic target in T1D.

Keywords: Autoimmunity; Beta cells; Diabetes; Endocrinology; Innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • Cohort Studies
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 1 / virology*
  • Endogenous Retroviruses / drug effects*
  • Endogenous Retroviruses / genetics
  • Endogenous Retroviruses / pathogenicity
  • Female
  • Humans
  • Hyperglycemia / complications
  • Insulin / metabolism
  • Insulin Antagonists / pharmacology
  • Islets of Langerhans / metabolism
  • Male
  • Mice
  • Mice, Transgenic
  • RNA, Viral / blood
  • Viral Envelope Proteins / drug effects
  • Viral Envelope Proteins / physiology*

Substances

  • Antiviral Agents
  • Insulin
  • Insulin Antagonists
  • RNA, Viral
  • Viral Envelope Proteins